2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.537

Change

+0.03 (+0.51)%

Market Cap

USD 0.52B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-31 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.45% 75% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.45% 75% C 73% C
Trailing 12 Months  
Capital Gain 21.71% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.71% 81% B- 79% B-
Trailing 5 Years  
Capital Gain 54.94% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.94% 67% D+ 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 5.54% 55% F 54% F
Dividend Return 5.54% 54% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.63% 44% F 55% F
Risk Adjusted Return 40.67% 50% F 53% F
Market Capitalization 0.52B 67% D+ 59% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.